Explore by…


Öner Tulum

Öner Tulum is a research associate at The Academic-Industry Research Network (theAIRnet) and a visiting scholar at the University of Massachusetts Amherst. He is completing his PhD at the University of Ljubljana where his current research efforts concentrate on the examination of the prevailing productivity crisis in the U.S. biopharmaceutical industry and the impacts of the financialization of the high-tech economy on the development and sustainability of organizational capabilities.

By this expert

US Pharma’s Financialized Business Model

Paper Working Paper Series | | Jul 2017

Price gouging in the US pharmaceutical drug industry goes back more than three decades. 

Global Tax Dodging Just One Part of Pfizer’s Corrupt Business Model

Article | Dec 3, 2015

Why are we paying for corporate behavior that crushes innovation, cheats taxpayers, cost jobs, and heightens inequality?